Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

76.29

+2.17 (2.93%)

At close: Apr 17, 2026, 4:00 PM EDT

76.10

-0.19 (-0.25%)

After-hours: Apr 17, 2026, 7:00 PM EDT

Veradermics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-70	-26.49	-16.49
Stock-Based Compensation	1.44	0.25	0.21
Other Adjustments	0.84	1.82	1.85
Changes in Accounts Payable	-0.12	0.65	1.35
Changes in Accrued Expenses	4.51	1.27	0.55
Changes in Other Operating Activities	-8.27	-1.19	-0.98
Operating Cash Flow	-71.6	-23.69	-13.51
Capital Expenditures	-0.02	-	-
Purchases of Investments	-143.85	-	-
Proceeds from Sale of Investments	25.02	-	-
Investing Cash Flow	-118.86	-	-
Long-Term Debt Issued	-	8.51	-
Long-Term Debt Repaid	-	-0.85	-
Net Long-Term Debt Issued (Repaid)	-	7.66	-
Issuance of Common Stock	0.16	-	-
Net Common Stock Issued (Repurchased)	0.16	-	-
Issuance of Preferred Stock	159.43	53.1	13.93
Net Preferred Stock Issued (Repurchased)	159.43	53.1	13.93
Other Financing Activities	-0.45	-0.28	-0.04
Financing Cash Flow	159.14	60.48	13.9
Net Cash Flow	-31.32	36.79	0.39
Free Cash Flow	-71.63	-23.69	-13.51
Free Cash Flow Per Share	-96.14	-32.14	-18.33
Levered Free Cash Flow	-87.28	-18.91	-15.57
Unlevered Free Cash Flow	-76.26	-26.05	-16.4

Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q